15 results
PRE 14A
DAWN
Day One Biopharmaceuticals, Inc.
18 Apr 23
Preliminary proxy
4:05pm
ABOUT THE MEETING
BOARD OF DIRECTORS AND COMMITTEES OF THE BOARD OF DIRECTORS; CORPORATE GOVERNANCE STANDARDS AND DIRECTOR INDEPENDENCE
NOMINATIONS … AND COMMITTEES OF THE BOARD OF DIRECTORS;
CORPORATE GOVERNANCE STANDARDS AND DIRECTOR INDEPENDENCE
We are strongly committed to good corporate governance
S-3
EX-1.2
DAWN
Day One Biopharmaceuticals, Inc.
1 Jun 22
Shelf registration
4:06pm
recent Annual Report on Form 10-K under the captions “Legal Proceedings” and “Certain Relationships and Related Transactions, and Director Independence
DEF 14A
uglxtceap30h41zjmfv
28 Apr 22
Definitive proxy
4:44pm
10-K
go3mdxnxj8ovmym3
7 Mar 22
Annual report
7:36am
10-Q
EX-3.2
6lagrccc ikmasrw
10 Aug 21
Quarterly report
5:26pm
424B4
br8g urmx4e
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
dnffxq9dfk258jjj
24 May 21
IPO registration (amended)
6:16am
S-1
cmpsbjpl8w ws
4 May 21
IPO registration
4:12pm
S-1
EX-3.5
r6vqzjs7bmhgb d9f
4 May 21
IPO registration
4:12pm
S-1
EX-10.4
gxohl3n 7bcxc
4 May 21
IPO registration
4:12pm
DRS
sghkrakk
19 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next